NCCN 2010: Dr. Lee Krug, Memorial Sloan-Kettering Cancer Center

Article

Lee M. Krug, MD of the Memorial Sloan-Kettering Cancer Center speaks about New NCCN Guidelines for Mesothelioma at the 15th Annual NCCN Conference in Hollywood, FL March, 2010.

Recent Videos
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
Lucy Mathew, NP
Lavinia Iordache, PA
HCPLive Five at ESC 2024 | Image Credit: HCPLive
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Ascites | Credit: PixaBay
Melissa Franco, PA | Credit: University of Miami
Related Content
Kenneth Gordon, MD | Credit: International Psoriasis Council

Long-Term Safety Data Highlight Potential of Bimekizumab in Plaque Psoriasis

Patrick Campbell
September 18th 2024
Article
default thumbnail for Don't Miss a Beat podcast.

Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data

Muthiah Vaduganathan, MD, MPH;Stephen Greene, MD
September 2nd 2024
Podcast
Inadequate Eczema Control Observed in 30% of Patients on Topicals, Systemic Therapies

Inadequate Eczema Control Observed in 30% of Patients on Topicals, Systemic Therapies

Tim Smith
September 16th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: Sotagliflozin for T1D and Other ADCES 2024 Highlights

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
August 21st 2024
Podcast
Rapid Scalp, Nail Pain, Itch Improvements Observed with Ixekizumab Treatment of Psoriasis

Rapid Scalp, Nail Pain, Itch Improvements Observed with Ixekizumab Treatment of Psoriasis

Tim Smith
September 16th 2024
Article
Study Highlights Laboratory Parameters in 4 Years of Psoriasis Treatment with Deucravacitinib

Study Highlights Laboratory Parameters in 4 Years of Psoriasis Treatment with Deucravacitinib

Tim Smith
September 16th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.